ctrl K

AI Score

Unlock

Terns Pharmaceuticals Inc... (TERN)

AI Score

Unlock

3.69

0.00 (0.00%)

At close: Feb 28, 2025, 3:59 PM

3.70

0.14%

After-hours: Feb 28, 2025, 06:10 PM EST

Terns Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	1M	n/a	n/a	n/a
Cost of Revenue	881K	1.03M	512K	394K	195K	65K
Gross Profit	-881K	-1.03M	488K	-394K	-195K	-65K
Operating Income	-102.56M	-62.03M	-49.86M	-37.02M	-70.2M	-18.45M
Interest Income	12.9M	2.11M	170K	55K	1.2M	332K
Pretax Income	-89.97M	-59.99M	-49.65M	-39.76M	-68.84M	-18.09M
Net Income	-90.21M	-60.34M	-50.16M	-40.57M	-68.82M	-17.71M
Selling & General & Admin	39.06M	22.41M	19.55M	9M	8.66M	3.9M
Research & Development	63.5M	39.62M	31.31M	28.03M	61.53M	14.55M
Other Expenses	n/a	-68K	40K	-2.79M	154K	38K
Operating Expenses	102.56M	62.03M	50.86M	37.02M	70.2M	18.45M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	102.56M	62.03M	50.86M	37.02M	70.2M	18.45M
Income Tax	239K	358K	508K	813K	-20K	-67K
Shares Outstanding (Basic)	71.26M	36.03M	25.27M	25.13M	25.1M	23.97M
Shares Outstanding (Diluted)	71.26M	36.03M	25.27M	25.13M	25.1M	23.97M
EPS (Basic)	-1.27	-1.67	-1.98	-1.61	-2.74	-0.74
EPS (Diluted)	-1.27	-1.67	-1.98	-1.61	-2.74	-0.74
EBITDA	-102.27M	-58.95M	-49.35M	-36.63M	-35M	-18.39M
Depreciation & Amortization	292K	1.03M	512K	394K	195K	65K